These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1944893)
1. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats. Schneider JS; Rothblat DS Neuroscience; 1991; 44(2):421-9. PubMed ID: 1944893 [TBL] [Abstract][Full Text] [Related]
2. Regional differences in striatal dopamine uptake and release associated with recovery from MPTP-induced parkinsonism: an in vivo electrochemical study. Rothblat DS; Schneider JS J Neurochem; 1999 Feb; 72(2):724-33. PubMed ID: 9930746 [TBL] [Abstract][Full Text] [Related]
3. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism. Frohna PA; Rothblat DS; Joyce JN; Schneider JS Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343 [TBL] [Abstract][Full Text] [Related]
4. Repeated exposure to MPTP does not produce a permanent movement disorder in cats recovered from MPTP-induced parkinsonism. Rothblat DS; Schneider JS Neurodegeneration; 1995 Mar; 4(1):87-92. PubMed ID: 7600188 [TBL] [Abstract][Full Text] [Related]
5. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons. Rothblat DS; Schneider JS Brain Res Bull; 1994; 34(3):309-12. PubMed ID: 7914468 [TBL] [Abstract][Full Text] [Related]
7. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs. Wade TV; Schneider JS J Neurosci; 2001 Jul; 21(13):4901-7. PubMed ID: 11425917 [TBL] [Abstract][Full Text] [Related]
9. Responses of striatal neurons to peripheral sensory stimulation in symptomatic MPTP-exposed cats. Schneider JS Brain Res; 1991 Mar; 544(2):297-302. PubMed ID: 2039944 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study. Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593 [TBL] [Abstract][Full Text] [Related]
11. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats. Rothblat DS; Schneider JS Brain Res; 1995 Dec; 705(1-2):1-14. PubMed ID: 8821727 [TBL] [Abstract][Full Text] [Related]
12. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Pifl C; Schingnitz G; Hornykiewicz O Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053 [TBL] [Abstract][Full Text] [Related]
14. Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Schneider JS; Rothblat DS; DiStefano L Brain Res; 1994 Apr; 643(1-2):86-91. PubMed ID: 8032935 [TBL] [Abstract][Full Text] [Related]
15. Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation. Schneider JS; Schroeder JA; Rothblat DS Brain Res; 1998 Nov; 813(1):82-7. PubMed ID: 9824674 [TBL] [Abstract][Full Text] [Related]
16. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Sundström E; Fredriksson A; Archer T Brain Res; 1990 Oct; 528(2):181-8. PubMed ID: 2271921 [TBL] [Abstract][Full Text] [Related]
17. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry. Schneider JS; Yuwiler A; Markham CH Exp Neurol; 1986 Feb; 91(2):293-307. PubMed ID: 3484707 [TBL] [Abstract][Full Text] [Related]
18. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701 [TBL] [Abstract][Full Text] [Related]
19. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain. Schneider JS; Denaro FJ J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510 [TBL] [Abstract][Full Text] [Related]